Contagion®
@contagionlive.bsky.social
Providing timely news to improve the diagnosis, treatment, and prevention of infectious diseases.
Read our coverage: contagionlive.com
Read our coverage: contagionlive.com
Former FDA Chief Scientist, Jesse L. Goodman, MD, MPH, provides insights on the potential consequences of these new recommendations. #IDsky #Medsky
How Should We Interpret the Changes to the Childhood Vaccine Schedule? | Contagion Live
Former FDA Chief Scientist, Jesse L. Goodman, MD, MPH, provides insights on the potential consequences of these new recommendations.
www.contagionlive.com
January 6, 2026 at 9:31 PM
Sharon Carrasco DNP, APRN, ACNS-BC, ANP-C, CEN, FAEN, FAAN, FNAP, talks about safely responding to deadly pathogens such as Ebola and Lassa fever, and where the US is in terms of thinking about preparedness on a national level. #IDsky #Medsky
Managing Readiness for High-Consequence Infectious Disease | Contagion Live
Sharon Carrasco DNP, APRN, ACNS-BC, ANP-C, CEN, FAEN, FAAN, FNAP, talks about safely responding to deadly pathogens such as Ebola and Lassa fever, and where the US is in terms of thinking about prepar...
www.contagionlive.com
January 6, 2026 at 2:56 PM
#Breaking New federal guidance recommends childhood vaccines for 11 diseases downsizing immunization protection from the previous list of 18 diseases. #IDsky #Medsky
www.contagionlive.com/view/us-comp...
www.contagionlive.com/view/us-comp...
US Completely Revamps Childhood Vaccine Schedule to Resemble Small European Country | Contagion Live
Federal guidance recommends childhood vaccines for 11 diseases downsizing immunization protection from the previous list of 18 diseases.
www.contagionlive.com
January 5, 2026 at 9:23 PM
#Breaking New federal guidance recommends childhood vaccines for 11 diseases downsizing immunization protection from the previous list of 18 diseases. #IDsky #Medsky
www.contagionlive.com/view/us-comp...
www.contagionlive.com/view/us-comp...
A delay in providing standard infant vaccinations is associated with children not receiving MMR (measles, mumps, rubella) vaccine by 2 years of age.
Late Infant Vaccinations Linked to Children not Receiving MMR | Contagion Live
A delay in providing standard infant vaccinations is associated with children not receiving MMR (measles, mumps, rubella) vaccine by 2 years of age.
www.contagionlive.com
January 5, 2026 at 3:57 PM
A delay in providing standard infant vaccinations is associated with children not receiving MMR (measles, mumps, rubella) vaccine by 2 years of age.
.@jgpharmd.bsky.social discusses the series of politically driven actions, including defunding mRNA research, dismantling vaccine advisory bodies, and restricting CDC recommendations, that have undermined vaccine access, but professional societies, states are stepping in to preserve public health.
Destruction from Within, Resistance from Without | Contagion Live
A series of politically driven actions in 2025—including defunding mRNA research, dismantling vaccine advisory bodies, and restricting CDC recommendations—has undermined US vaccine access and pandemic...
www.contagionlive.com
January 4, 2026 at 2:08 PM
.@jgpharmd.bsky.social discusses the series of politically driven actions, including defunding mRNA research, dismantling vaccine advisory bodies, and restricting CDC recommendations, that have undermined vaccine access, but professional societies, states are stepping in to preserve public health.
Read about increasing influenza activity, an approach to de-escalating empiric broad spectrum antibiotics for clinically stable patients with community-onset sepsis, and more.
Top Infectious Disease News Stories Week of December 27 - January 2 | Contagion Live
This week, read about increasing influenza activity, an approach to de-escalating empiric broad spectrum antibiotics for clinically stable patients with community-onset sepsis, and more Emory Healthca...
www.contagionlive.com
January 3, 2026 at 2:43 PM
Read about increasing influenza activity, an approach to de-escalating empiric broad spectrum antibiotics for clinically stable patients with community-onset sepsis, and more.
Jill Morgan, RN, BSN, talks about steps being taken to ensure everyone’s safety is front of mind. #IDsky #Medsky
Increasing PPE Standards to Protect Patients, Healthcare Workers | Contagion Live
Jill Morgan, RN, BSN, talks about steps being taken to ensure everyone’s safety is front of mind.
www.contagionlive.com
January 2, 2026 at 8:42 PM
CDC surveillance shows sharp week-over-week increases in influenza test positivity, outpatient illness, and hospital admissions, with A(H3N2) continuing to predominate nationwide. #IDsky #Medsky
US Influenza Activity Accelerates Into the New Year as Hospitalizations Rise | Contagion Live
CDC surveillance shows sharp week-over-week increases in influenza test positivity, outpatient illness, and hospital admissions, with A(H3N2) continuing to predominate nationwide.
www.contagionlive.com
January 2, 2026 at 2:23 PM
Jill Morgan, RN, BSN, reviews this significant part of clinical care and how personal protective equipment (PPE) is essential to protecting healthcare workers. #IDsky #medsky
Addressing the Three Pillars of PPE in Caring for Patients with High-Consequence Infectious Disease | Contagion Live
Jill Morgan, RN, BSN, reviews this significant part of clinical care and how personal protective equipment (PPE) is essential to protecting healthcare workers.
www.contagionlive.com
December 31, 2025 at 4:16 PM
The recent CDC ACIP meetings and subsequent actions show a path for which the current Health and Human Services department wants to roll back access to vaccines for this virus and other vaccines. #IDsky #Medsky
CDC's Latest Hepatitis B Vaccine Guidance Serves as Example for Future Federal Vaccine Policy | Contagion Live
The recent CDC ACIP meetings and subsequent actions show a path for which the current Health and Human Services department wants to roll back access to vaccines for this virus and other vaccines.
www.contagionlive.com
December 31, 2025 at 2:01 PM
Emory's Gavin Harris, MD, discusses these elements, and how despite the fact they rarely occur, the need to do continuous training is essential for readiness. #IDsky #Medsky
Vigilance, Training, and Funding are Key for Outbreak and Pandemic Biopreparedness | Contagion Live
Emory's Gavin Harris, MD, discusses these elements, and how despite the fact they rarely occur, the need to do continuous training is essential for readiness.
www.contagionlive.com
December 30, 2025 at 2:24 PM
Shortening course of empiric broad spectrum antibiotics for community-onset sepsis was associated with fewer days of antibiotics and hospitalization and no increase in mortality. #IDsky #Medsky
Antibiotic De-Escalation Demonstrates Advantages for Community-Onset Sepsis | Contagion Live
Shortening course of empiric broad spectrum antibiotics for community-onset sepsis was associated with fewer days of antibiotics and hospitalization and no increase in mortality.
www.contagionlive.com
December 29, 2025 at 3:56 PM
This week, check out our Media Day coverage from Emory, the WHO report on malaria, and more. #IDsky #Medsky
www.contagionlive.com/view/top-inf...
www.contagionlive.com/view/top-inf...
Top Infectious Disease News Stories Week of December 20 - December 26 | Contagion Live
This week, check out our Media Day coverage from Emory, the WHO report on malaria, and more.
www.contagionlive.com
December 27, 2025 at 1:52 PM
This week, check out our Media Day coverage from Emory, the WHO report on malaria, and more. #IDsky #Medsky
www.contagionlive.com/view/top-inf...
www.contagionlive.com/view/top-inf...
In the final installment of the series, psychiatrist Robert C Bransfield, MD, outlines how interdisciplinary research, education, and policy could help reduce infection-associated neuropsychiatric impairment and violence.
From Awareness to Prevention: Addressing the Infection–Mental Illness–Violence Continuum | Contagion Live
In the final installment of the series, psychiatrist Robert C Bransfield, MD, outlines how interdisciplinary research, education, and policy could help reduce infection-associated neuropsychiatric imp...
www.contagionlive.com
December 26, 2025 at 1:59 PM
In the final installment of the series, psychiatrist Robert C Bransfield, MD, outlines how interdisciplinary research, education, and policy could help reduce infection-associated neuropsychiatric impairment and violence.
In the second installment of this 2-part article on the WHO 2025 World Malaria Report, the authors point out the positive trends in the scaling up of prevention efforts with new-generation anti-mosquito netting, vaccines and periodic chemoprevention.
www.contagionlive.com/view/who-fin...
www.contagionlive.com/view/who-fin...
WHO Finds Progress in Malaria Prevention Measures | Contagion Live
In the second installment of this 2-part article on the WHO 2025 World Malaria Report, the authors point out the positive trends in the scaling up of prevention efforts with new-generation anti-mosqui...
www.contagionlive.com
December 24, 2025 at 2:02 PM
In the second installment of this 2-part article on the WHO 2025 World Malaria Report, the authors point out the positive trends in the scaling up of prevention efforts with new-generation anti-mosquito netting, vaccines and periodic chemoprevention.
www.contagionlive.com/view/who-fin...
www.contagionlive.com/view/who-fin...
The WHO 2025 World Malaria Report adds several countries to those certified as malaria free, while recognizing spread of antimalarial drug resistance.
WHO Certifies Countries as Malaria Free in Face of Persistent Antimalarial Drug Resistance | Contagion Live
The WHO 2025 World Malaria Report adds several countries to those certified as malaria free, while recognizing spread of antimalarial drug resistance.
www.contagionlive.com
December 23, 2025 at 6:32 PM
The WHO 2025 World Malaria Report adds several countries to those certified as malaria free, while recognizing spread of antimalarial drug resistance.
Amy Colson, MD, MPH, discusses phase 2 data showing durable virologic suppression, low resistance risk, and favorable safety with weekly oral islatravir plus lenacapavir in suppressed adults with HIV.
Once-Weekly Oral Islatravir Plus Lenacapavir Maintains HIV Suppression Through 48 Weeks | Contagion Live
Amy Colson, MD, MPH, discusses phase 2 data showing durable virologic suppression, low resistance risk, and favorable safety with weekly oral islatravir plus lenacapavir in suppressed adults with HIV-...
www.contagionlive.com
December 23, 2025 at 2:50 PM
Amy Colson, MD, MPH, discusses phase 2 data showing durable virologic suppression, low resistance risk, and favorable safety with weekly oral islatravir plus lenacapavir in suppressed adults with HIV.
Dr. Gavin Harris discusses his experience working in outbreak environments where there is high-consequence infectious disease and how it is important to establish buy-in from the local populations and some of the important elements of what you need to leave behind when an outbreak is declared over.
Working in a Hot Zone: Building Trust With Local Communities, Addressing Gaps In Preparedness | Contagion Live
Gavin Harris, MD, discusses his experience working in outbreak environments where there is high-consequence infectious disease (HCID) and how it is important to establish buy-in from the local populat...
www.contagionlive.com
December 22, 2025 at 5:22 PM
Dr. Gavin Harris discusses his experience working in outbreak environments where there is high-consequence infectious disease and how it is important to establish buy-in from the local populations and some of the important elements of what you need to leave behind when an outbreak is declared over.
Agreement supports commercialization and reimbursement efforts for tobevibart plus elebsiran as the ECLIPSE clinical program advances, including completion of enrollment for the ECLIPSE 3 trial.
Vir Grants Norgine Commercial Rights to Hepatitis Delta Therapy in Europe, Australia, and New Zealand | Contagion Live
Agreement supports commercialization and reimbursement efforts for tobevibart plus elebsiran as the ECLIPSE clinical program advances, including completion of enrollment for the ECLIPSE 3 trial.
www.contagionlive.com
December 22, 2025 at 3:39 PM
Agreement supports commercialization and reimbursement efforts for tobevibart plus elebsiran as the ECLIPSE clinical program advances, including completion of enrollment for the ECLIPSE 3 trial.
#ICYMI: The Fall/Winter issue is out! Read further about lenacapavir's role in PrEP, the 2025 CLSI Subcommittee recommendations for antimicrobial susceptibility testing, an update on non–carbapenemase-producing carbapenem-resistant Enterobacterales, and more.
www.contagionlive.com/view/contagi...
www.contagionlive.com/view/contagi...
Contagion Fall/Winter 2025-2026 Digital Edition | Contagion Live
View our interactive Fall/Winter 2025-2026 digital edition.
www.contagionlive.com
December 22, 2025 at 1:25 PM
#ICYMI: The Fall/Winter issue is out! Read further about lenacapavir's role in PrEP, the 2025 CLSI Subcommittee recommendations for antimicrobial susceptibility testing, an update on non–carbapenemase-producing carbapenem-resistant Enterobacterales, and more.
www.contagionlive.com/view/contagi...
www.contagionlive.com/view/contagi...
The single-source award will fund a large randomized trial evaluating mortality, morbidity, and developmental outcomes following the hepatitis B birth dose, amid ongoing debate over non-specific vaccine effects.
CDC Awards Grant to Study Neonatal Hepatitis B Vaccination Outcomes in Guinea-Bissau | Contagion Live
The single-source award will fund a large randomized trial evaluating mortality, morbidity, and developmental outcomes following the hepatitis B birth dose, amid ongoing debate over non-specific vacci...
www.contagionlive.com
December 21, 2025 at 12:46 PM
The single-source award will fund a large randomized trial evaluating mortality, morbidity, and developmental outcomes following the hepatitis B birth dose, amid ongoing debate over non-specific vaccine effects.
Our Fall/Winter issue is out! Read the latest in infectious disease including lenacapavir's role in PrEP, the 2025 CLSI Subcommittee recommendations for antimicrobial susceptibility testing, and more.
Check out the issue here: www.contagionlive.com/view/contagi...
Check out the issue here: www.contagionlive.com/view/contagi...
December 20, 2025 at 2:33 PM
Our Fall/Winter issue is out! Read the latest in infectious disease including lenacapavir's role in PrEP, the 2025 CLSI Subcommittee recommendations for antimicrobial susceptibility testing, and more.
Check out the issue here: www.contagionlive.com/view/contagi...
Check out the issue here: www.contagionlive.com/view/contagi...
This week, learn more about Emory's approach around treating high-consequence infectious diseases such as Ebola, a UNC researcher's work in sequencing syphilis genomes in the search to develop a global vaccine, how the US is in danger of losing its elimination status for measles, and more.
Top Infectious Disease News Stories Week of December 13 - December 19 | Contagion Live
This week, learn more about Emory's approach around treating high-consequence infectious diseases such as Ebola, a UNC researcher's work in sequencing syphilis genomes in the search to develop a globa...
www.contagionlive.com
December 20, 2025 at 1:02 PM
This week, learn more about Emory's approach around treating high-consequence infectious diseases such as Ebola, a UNC researcher's work in sequencing syphilis genomes in the search to develop a global vaccine, how the US is in danger of losing its elimination status for measles, and more.
Emory's Gavin Harris, MD, talks about taking care of patients with high-consequence infectious diseases, and working with other healthcare facilities around COVID-19 care and educating them through Emory's ECHO program on new and existing threats.
Emory Healthcare: Melding Critical Care, Infectious Diseases, and Disaster Preparedness Together | Contagion Live
Emory's Gavin Harris, MD, talks about taking care of patients with high-consequence infectious diseases, and considerations for not only their care, but their families. He also discusses working with ...
www.contagionlive.com
December 19, 2025 at 9:18 PM
Emory's Gavin Harris, MD, talks about taking care of patients with high-consequence infectious diseases, and working with other healthcare facilities around COVID-19 care and educating them through Emory's ECHO program on new and existing threats.
Zandraetta Tims-Cook, MD, MPH, AAHIVS, discusses access challenges, missed-dose management, and scalable care models for cabotegravir PrEP in women.
Long-Acting Injectable PrEP for Women: Real-World Barriers, Counseling, and Clinic Strategies | Contagion Live
Zandraetta Tims-Cook, MD, MPH, AAHIVS, discusses access challenges, missed-dose management, and scalable care models for cabotegravir PrEP in women.
www.contagionlive.com
December 19, 2025 at 5:00 PM
Zandraetta Tims-Cook, MD, MPH, AAHIVS, discusses access challenges, missed-dose management, and scalable care models for cabotegravir PrEP in women.